TrialJournal of immunology research2020

Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.

Anne Rogiers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.